Ligand Pharmaceuticals Inc
LGND· Nasdaq
LGNDLigand Pharmaceuticals Inc
Source filing unavailable
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $7.46M | $5.84M |
| Net Income | -$422.00K | -$283.00K |
| EPS Diluted | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
